Dr. Petar Ozretić is a Senior Research Associate and Head of the Laboratory for Hereditary Cancer at the Ruđer Bošković Institute (RBI) in Zagreb, Croatia. After receiving a Diploma degree in Molecular Biology at the Faculty of Science, University of Zagreb in 2005, he was employed as a Professional Associate at the RBI in 2006. Under the mentorship of Prof. Sonja Levanat and Prof. Alberto Inga, he obtained a PhD degree in Biomedicine and Health in 2013. He was a Senior Assistant at the RBI until 2017 when he was promoted to a Research Associate. He is an Adjunct Assistant Professor at the JJ Strossmayer University of Osijek from 2018. He mentored one PhD and seven Diploma theses. He was participating in 25 projects as an associate or PI. His research interests include regulation of the Hedgehog signaling pathway by ncRNAs, interaction between SHH protein and sex hormone receptors, and the role of m1A RNA modification in head and neck tumors. He is a member of the Editorial Council of Libri Oncologioci Croatian Journal of Oncology, a Technical Editor of Periodicum biologoum journal, reviewer for numerous journals (reviewed more than 700 manuscripts). He has published 58 scientific articles, which have been cited ~1500 times (Google Scholar's H-index 20). He is a member of 10 professional associations, and from 2009 he is a Secretary of the Croatian Association for Cancer Research (HDIR), national society affiliated to the European Association for Cancer Research (EACR).

'FEBS Communications' posts general items from the FEBS Network Team as well as news on FEBS events and other activities.

I became an MD in 1972, then decided to do research in biomedical sciences and received my PhD in immunology in 1978. I spent 3 years as a postdoctoral fellow at NIH, USA, then started a university carrier in Debrecen where became professor of biochemistry and molecular biology in 1988 at the Faculty of Medicine, then chairman of this department between 1993 and 2013. My research group has focused on molecular mechanisms in cell death, structure and function of transglutaminases with clinical implications, inflammation, differentiation and functions of white and brown adipocytes. I was visiting professor at the University of Texas and the University of Rome, coordinated major European projects of COST, ESF and EU-Frame Work programs. I was rector (1999-2001, 2007-2010) and president of the Medical and Health Science Center (2001-2007) of the University of Debrecen. Elected to chair the Hungarian Accreditation Committee for Higher Education (2004-2007), the Hungarian Biochemical Society (2005-2015) and became a member of the Hungarian Academy of Sciences in 1998 where chaired the Science and Ethics Committee and currently chair the Biology Section of the Academy. In 2010 I was elected to be the member of the Committee on Science and Ethics of All European Academies (ALLEA) and participated in the drafting group of the recently published new European Code of Conduct for Research Integrity. . Since 2012 I chair the Publications Committee of the Federation of European Biochemical Societies and I am member of FEBS Executive Committee.

genomics, IVF, RNA, biomarkers, epigenetics, transcription, personalized medicine, diagnostic development, FAIR, superenhancers, data management, estrogen, nuclear receptors